MicroRNA Post-transcriptional Regulation of the NLRP3 Inflammasome in Immunopathologies

Loading...
Thumbnail Image

Authors

Tezcan, Gulcin
Martynova, Ekaterina V.
Gilazieva, Zarema E.
McIntyre, Alan
Rizvanov, Albert A.
Khaiboullina, Svetlana F.

Issue Date

2019

Type

Article

Language

Keywords

NLRP3 , inflammasome , microRNA , inflammation , disease

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

Inflammation has a crucial role in protection against various pathogens. The inflammasome is an intracellular multiprotein signaling complex that is linked to pathogen sensing and initiation of the inflammatory response in physiological and pathological conditions. The most characterized inflammasome is the NLRP3 inflammasome, which is a known sensor of cell stress and is tightly regulated in resting cells. However, altered regulation of the NLRP3 inflammasome is found in several pathological conditions, including autoimmune disease and cancer. NLRP3 expression was shown to be post-transcriptionally regulated and multiple miRNA have been implicated in post-transcriptional regulation of the inflammasome. Therefore, in recent years, miRNA based post-transcriptional control of NLRP3 has become a focus of much research, especially as a potential therapeutic approach. In this review, we provide a summary of the recent investigations on the role of miRNA in the post-transcriptional control of the NLRP3 inflammasome, a key regulator of pro-inflammatory IL-1 beta and IL-18 cytokine production. Current approaches to targeting the inflammasome product were shown to be an effective treatment for diseases linked to NLRP3 overexpression. Although utilizing NLRP3 targeting miRNAs was shown to be a successful therapeutic approach in several animal models, their therapeutic application in patients remains to be determined.

Description

Citation

Tezcan, G., Martynova, E. V., Gilazieva, Z. E., McIntyre, A., Rizvanov, A. A., & Khaiboullina, S. F. (2019). MicroRNA Post-transcriptional Regulation of the NLRP3 Inflammasome in Immunopathologies. Frontiers in Pharmacology, 10. doi:10.3389/fphar.2019.00451

Publisher

License

Creative Commons Attribution 4.0 International

Journal

Volume

Issue

PubMed ID

ISSN

1663-9812

EISSN

Collections